2008
DOI: 10.1002/ajmg.a.32581
|View full text |Cite
|
Sign up to set email alerts
|

Setting a public health research agenda for Down syndrome: Summary of a meeting sponsored by the Centers for Disease Control and Prevention and the National Down Syndrome Society

Abstract: On November 8-9, 2007, a meeting entitled "Setting a Public Health Research Agenda for Down Syndrome" was held to review current knowledge, identify gaps, and develop priorities for future public health research related to Down syndrome. Participants included experts in clinical and molecular genetics, pediatrics, cardiology, psychiatry, psychology, neuroscience, epidemiology, and public health. Participants were asked to identify key public health research questions and discuss potential strategies that could… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
46
0
1

Year Published

2009
2009
2017
2017

Publication Types

Select...
10

Relationship

4
6

Authors

Journals

citations
Cited by 55 publications
(49 citation statements)
references
References 112 publications
0
46
0
1
Order By: Relevance
“…A rigorous evidence-based review of screening and treatment for atlantoaxial instability, for example, is needed, 94 and continuing research is critical for directing the care for optimal outcomes of persons with Down syndrome. 1,95,96 …”
Section: Future Considerationsmentioning
confidence: 99%
“…A rigorous evidence-based review of screening and treatment for atlantoaxial instability, for example, is needed, 94 and continuing research is critical for directing the care for optimal outcomes of persons with Down syndrome. 1,95,96 …”
Section: Future Considerationsmentioning
confidence: 99%
“…5 No population-based registry exists for people with DS in the United States, although the need has been highlighted at national conferences. 6,7 In a recent study, de Graaf et al 8 used and validated an alternative approach for the United Kingdom, the Netherlands, and Ireland. In estimating population prevalence, the model uses maternal-age birth data in the general population, maternal age-related chances for a live birth with DS, data regarding elective terminations, and DS-specific mortality rates.…”
Section: Introductionmentioning
confidence: 99%
“…Virtually no attention has been paid to research involving ongoing DS pregnancies (7); however, functional analyses of the molecular changes in DS may allow development of testable hypotheses that could identify targets for novel treatments in utero.…”
mentioning
confidence: 99%